3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
9
Neoplasms
4
Neoplasm Metastasis
4
Multiple Myeloma
4
Gastrointestinal Stromal Tumors
4
Thyroid Neoplasms
2
Pancreatic Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Kidney Neoplasms
2
Gastrointestinal Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neoplasms by Site
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Meningioma
1
Interventions
AZD 6244
7
trametinib
4
mirdametinib
2
fludarabine
2
Inhalation
2
Acetylcysteine
2
thymoglobulin
1
talimogene laherparepvec
1
omipalisib
1
lorlatinib
1
fludarabine phosphate
1
encorafenib
1
dabrafenib
1
binimetinib
1
abemaciclib
1
Vincristine
1
Specimen Handling
1
Sirolimus
1
Rituximab
1
Radiation
1
N-monoacetylcystine
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Levetiracetam
1
Lasers, Solid-State
1
Lasers
1
Injections
1
Deoxycholic Acid
1
Cytarabine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibromatosis 1
×
Sunitinib
×
90 days
×
Clear all
No trials found.